Skip to content
777 Sourcing.

Capability

drug screening on biopsy tumor tissue

Suppliers
1
States & provinces
1
Countries
1

1 drug screening on biopsy tumor tissue supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CERFLUX INC

BIRMINGHAM, AL

CerFlux is a cancer biotechnology company that develops human-relevant ex vivo and in silico cancer models to accelerate personalized precision oncology by matching treatments to tumors. Its patented POET® (Personalized Oncology Efficacy Test) approach screens multiple therapy agents simultaneously on standard biopsy tissue from the patient's own tumor, matching treatments to tumors in less than 7 days before treatment begins.

ex vivo cancer modelingin silico cancer modelingpersonalized oncology efficacy testing

Compiled from public sources

Related capabilities

Other processes offered by the shops that list drug screening on biopsy tumor tissue.

Browse all capabilities